Leavitt Plans India Visit To Discuss Safe Pharmaceutical Exports (India)
This article was originally published in PharmAsia News
The head of the U.S. Department of Health and Human Services plans a January visit to India to discuss ways to make medicines and medical products safe for the U.S. market. During his visit, Secretary Mike Leavitt plans to visit sites that make drugs, food and other products intended for export to the United States. One of Leavitt's visits is to be made to a facility delivering polio vaccine, but his schedule also includes visits with business people and senior officials in the Indian government. (Click here for more
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.